Navigation Links
InspireMD Reports Financial Results for Quarter Ended September 30, 2013
Date:11/11/2013

forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
Phone: 212-896-1215 / 212-896-1250
Email: tfromer@kcsa.com / grussell@kcsa.com

Media Contacts:
Lewis Goldberg / Samantha Wolf
KCSA Strategic Communications
Phone: 212-896-1216 / 212-896-1220
Email: lgoldberg@kcsa.com / swolf@kcsa.com

 CONSOLIDATED STATEMENTS OF OPERATIONS (1)(U.S. dollars in thousands, except per share data)Three months endedSeptember 30,20132012Revenues$1,552$509Cost of Revenues

750230Gross Profit802279Operating Expenses:Research and development expenses

1,544946Selling and marketing

830402General and administrative

2,3132,212Total operating expenses

4,6873,560Loss from Operations

(3,885)(3,281)Financial expenses

574,218Loss before income taxes

(3,942)(7,499)Tax expenses

37Net Loss($3,945)($7,506)Net loss per share – basic and diluted

($0.12)($0.44)Weighted average number of shares of common stock used in
computing net loss per share – basic and diluted

33,959,77317,074,235 RECONCILIATION OF NON-GAAP NET LOSS (2)(U.S. dollars in thousands, except per share data)Three months endedSeptember 30,20132012GAAP Net Loss($3,945)($7,506)Non-GAAP Adjustments:Non
'/>"/>

SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015  Xcelience, a contract development and ... made a structured cash investment in Powdersize, a ... milling, micronization and powder size classification within the ... business while simultaneously adding a complete set of ... capabilities. "As we continue to ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 ... announced it has signed a definitive agreement ... provider of non-invasive ventilation and sleep-disordered breathing ... strong clinical, innovation and market reputation in China, combined with ResMed,s global leadership ... of people in China ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... LOS ANGELES, May 16, 2012  NeuroSigma, Inc., a ... its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a ... the fabrication of Thin-Film Nitinol (TFN) from TiNi ... "Three Dimensional Thin Film Devices and Methods of ...
... 2012  Rigel Pharmaceuticals, Inc., (Nasdaq: RIGL ) ... innovative, comprehensive treatment alternatives for patients with asthma. One ... be entering a Phase 2 clinical study later this ... R256, an inhaled IL13 signaling/JAK inhibitor, is potentially useful ...
Cached Medicine Technology:NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 2NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 2Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 4
(Date:7/31/2015)... , ... July 31, 2015 , ... ... Times magazine. What are the STASH awards? The Significant Technological Achievements in ... the cannabis-cultivation community as well as tried-and-true products that have stood the test ...
(Date:7/31/2015)... ... ... Ticket Down is a reliable source for authentic tickets for the 2015 ... The festival will end on Sunday, August 2nd. , Music fans have ... This unique and unbelievably popular festival attracts the best in entertainment from around the ...
(Date:7/31/2015)... ... ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest applicator for ... applicator in the United States as an upgrade to the CoolSmooth applicator cleared by ... required a 2 hour treatment time. The new CoolSmooth Pro reduces the treatment ...
(Date:7/31/2015)... ... 2015 , ... M3 USA MDLinx.com, source of the Smartest Doc Board Exam ... , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an already robust ... the exam easy and painless. MDLinx offers thousands of board-exam style questions and ...
(Date:7/31/2015)... York (PRWEB) , ... July ... ... attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now available ... 2015 was well received with a 94% approval rating from the nationwide ...
Breaking Medicine News(10 mins):Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) ... of lower back pain for an expensive MRI scan if ... indicates. The Stanford University School of Medicine researchers also ... significantly more likely to have back surgery within six months ...
... By Serena Gordon HealthDay Reporter , TUESDAY, April ... Jordyn leaves the house, Nancy Geller worries about the food ... peanut allergy, and exposure to even a small amount of ... "It,s a big worry, especially now that she,s a ...
... Researchers in the Faculty of Medicine & Dentistry at the ... a new understanding of how our immune system "learns" not ... way doctors treat patients with autoimmune diseases and cancer. ... experimental therapies to treat autoimmune diseases such as diabetes and ...
... producing large quantities of a much-needed new imaging agent for ... other diseases, and the first evidence that the material is ... oxide nanoparticle, which is inexpensive, and stays in the body ... in the Journal of the American Chemical Society . ...
... Weller, MD, Chief of both the Division of Allergy and ... Deaconess Medical Center (BIDMC), is the recipient of an ... Infectious Diseases. A Professor of Medicine at Harvard Medical School, ... Mechanisms of Functioning." An acronym for the Method to ...
... Minn. -- Global Bridges, a healthcare alliance for tobacco ... partner, the InterAmerican Heart Foundation (IAHF) in Dallas, Texas, ... courses for health care providers in Latin America on ... training, developed in collaboration with several regional and global ...
Cached Medicine News:Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 2Health News:When Docs Own MRIs, Back Pain Scans Increase: Study 3Health News:Anxiety's on the Menu for People With Food Allergies 2Health News:Anxiety's on the Menu for People With Food Allergies 3Health News:Discovery could change the way doctors treat patients with cancer and autoimmune diseases 2Health News:BIDMC's Peter Weller, M.D., receives NIH MERIT Award 2Health News:Health care alliance for tobacco dependence treatment launches training in Mexico 2Health News:Health care alliance for tobacco dependence treatment launches training in Mexico 3
... Contrast Sensitivity is Recognized as a ... Loss Caused by Early Eye Disease. ... in x 7 in (12.7cm x ... on a Refractor,Distance Test F.A.C.T. ...
Vision Testing for Infants and Non-Verbal Patients,Using Preferential Looking....
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Adult: Letter Acuity, Astigmatic Clock, Binocular Balance, Supression, Fixation Disparity, Stereopsis...
Medicine Products: